Updated on Jun 30, 2022 | Inside
Trailblazing neurogenetics researcher Alison M. Goate, DPhil, was presented with the Khalid Iqbal, PhD, Lifetime Achievement Award in Alzheimer’s Disease Research during the 2015 Alzheimer’s Association International Conference® held recently in Washington, D.C. The award honors individuals who have made significant, fundamental contributions to Alzheimer’s research, either through a single specific scientific discovery or a body of work. Dr. Goate, who has been studying the genetics of Alzheimer’s disease for more than 27 years, reported the first genetic mutation that causes an inherited form of Alzheimer’s and co-led a team of researchers that reported on some of the first disease-causing genetic mutations discovered for frontotemporal dementia. Her current research focuses on understanding the genetic risk factors for the more common, late-onset form of Alzheimer’s disease. Dr. Goate is Professor of Neuroscience, Genetics and Genomic Sciences, and Neurology for the Mount Sinai Health System and Director of the Ronald M. Loeb Center for Alzheimer’s Disease at the Icahn School of Medicine at Mount Sinai.
Updated on Jun 30, 2022 | Inside
Eight specialties within the Mount Sinai Health System were ranked among the top 25 in the nation, according to the 2015-2016 U.S. News & World Report Best Hospitals rankings, released in July. The specialties included seven at The Mount Sinai Hospital: Cardiology/Heart Surgery; Diabetes/Endocrinology; Ear, Nose & Throat (ENT); Gastroenterology/GI Surgery; Geriatrics; Nephrology; Neurology/Neurosurgery; and the Department of Ophthalmology at New York Eye and Ear Infirmary of Mount Sinai. Among the top 25, four specialties moved higher in the rankings between 2014 and 2015, led by Cardiology/Heart Surgery, which now stands at No. 7, up from No. 10; Gastroenterology/GI Surgery at No. 8, up from No. 9; Neurology/Neurosurgery at No. 14, up from No. 15; and Nephrology, which moved up to No. 23 from No. 47. (more…)
Updated on Jun 30, 2022 | Inside
A total of 241 physicians from the Mount Sinai Health System’s seven hospital campuses and an additional 34 physicians from Mount Sinai’s affiliated hospitals were represented in New York magazine’s recently released list of “Best Doctors in New York.” The 275 physicians represented 21 percent of the overall 1,282 area doctors on the 2015 list, available online and in the June 8-14, 2015, print edition. The list covers physicians from throughout the New York metropolitan region, including Connecticut and New Jersey. (more…)
Updated on Jun 30, 2022 | Inside, Research
A protein that promotes abnormal growth in melanoma cells has been identified for the first time by a team of researchers led by Emily Bernstein, PhD, Associate Professor of Oncological Sciences, and Dermatology, at the Icahn School of Medicine at Mount Sinai.
The novel discovery that the H2A.Z.2 protein is highly expressed in melanoma, appears to turn on the cell cycle, and makes melanoma cells grow faster, could also lead to therapeutic strategies that serve to inhibit cell proliferation. The results of Dr. Bernstein’s study were published in the July 2, 2015, issue of Molecular Cell. (more…)
Updated on Jun 30, 2022 | Inside, Your Health
The Mount Sinai Hospital recently opened the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at 17 East 102nd Street, a facility created to provide comprehensive care in one location for pediatric and adult patients. Inflammatory Bowel Disease (IBD) is a general classification of conditions that cause inflammation of the intestines. An estimated 1.4 million people in the United States have Crohn’s disease and ulcerative colitis. (more…)
Updated on Jun 30, 2022 | Inside, Research
Surviving spouses of patients who received hospice care for three or more days more frequently reported reduced depressive symptoms after the patient’s death compared to spouses of patients who did not receive hospice, according to a study by Icahn School of Medicine at Mount Sinai researchers. The findings were published recently in JAMA Internal Medicine. (more…)
Trailblazing neurogenetics researcher Alison M. Goate, DPhil, was presented with the Khalid Iqbal, PhD, Lifetime Achievement Award in Alzheimer’s Disease Research during the 2015 Alzheimer’s Association International Conference® held recently in Washington, D.C. The award honors individuals who have made significant, fundamental contributions to Alzheimer’s research, either through a single specific scientific discovery or a body of work. Dr. Goate, who has been studying the genetics of Alzheimer’s disease for more than 27 years, reported the first genetic mutation that causes an inherited form of Alzheimer’s and co-led a team of researchers that reported on some of the first disease-causing genetic mutations discovered for frontotemporal dementia. Her current research focuses on understanding the genetic risk factors for the more common, late-onset form of Alzheimer’s disease. Dr. Goate is Professor of Neuroscience, Genetics and Genomic Sciences, and Neurology for the Mount Sinai Health System and Director of the Ronald M. Loeb Center for Alzheimer’s Disease at the Icahn School of Medicine at Mount Sinai.
